5th ANNUAL
Clinical Trials
Innovation Summit
Innovation Summit
26 JUNE 2025 | BASEL | ROCHE BUILDING 1
PRESENTED BY
The Clinical Trials Innovation Summit returns to
Roche Headquarters in Basel on 26 June 2025!
Roche Headquarters in Basel on 26 June 2025!
PanAgora Pharma and Roche are collaborating once again to bring the 5th Annual Clinical Trials Innovation Summit back to Basel this 26 June! This year's conference agenda will explore how life sciences organizations are delivering more patient-centric clinical trials and how digital health technologies (DHTs) are being implemented to improve efficacy measurement, patient recruitment, safety, and drug delivery.
Core themes for the 2025 conference agenda:
• Industry Trends and Innovations in Virtual, Hybrid and Decentralized Trials: AI, DHT, Decentralized trials, Evolving Role of CRO’s, Global Perspective
• Patient Perspective: Keys to Engagement, Involvement, and Applying Learnings at Scale
• Identifying Innovations & Technologies Accelerating Patient-Centric Trials
• Ideas into Action: Keys to Delivering Inclusive Human-Centered Clinical Trials
Join 30+ speakers and 250+ senior-level clinical research, operations, and trial design leaders on 26 June at Roche headquarters in Basel!
Location
Date & Time
26 June 2025
09:00-17:30 Local Time (GMT+2)
Apéro to Follow
09:00-17:30 Local Time (GMT+2)
Apéro to Follow
HOST SPONSOR
AGENDA THEMES FOR 2025
1. Industry Trends and Latest Innovations in Virtual, Hybrid and Decentralized Trials: AI, DHT, Decentralized trials, Evolving Role of CRO’s, Global Perspective
2. Stakeholder Perspectives: Keys to Involving Patients & Sites Early On,
Learning, and Applying Learnings at Scale
3. Accelerating Patient-Centric Trials: Innovations & Technologies
4. Ideas into Action: Delivering Human-Centered Clinical Trials
SpeakING FACULTY & ADvisors
Sam Hariry
NOVARTIS
Léa Proulx
ROCHE
Ernst Bos
ROCHE
Paul Cooper
ROCHE
Scott Askin
NOVARTIS
Bola Grace
GSK
Nadir Ammour
SANOFI
Isabela Niculae
UCB
Suki Balendra
IMPERIAL COLLEGE HEALTHCARE NHS TRUST
Meri Kay Scott
ELI LILLY AND COMPANY
Dan Karlin
MINDMED
Lauren Sunshine
BRISTOL MYERS SQUIBB
Angela Bilkhu
ROCHE
Amri Johnson
INCLUSION WINS
Aude Clement
ROCHE
Steve Bourke
PERSONALPULSE
Bruno Jolain
ROCHE
Alison Holland
MEDABLE
Joachim Lövin
NOVO NORDISK
Thierry Lave
ROCHE
Conference Schedule
26 June 2025
09:00
Opening Remarks from the Conference Chairs
Ernst Bos, Global Medical Director, Roche
Paul Cooper, Personalised Healthcare Strategy Leader, Roche
CONTENT BLOCK 1
INDUSTRY TRENDS AND INNOVATIONS
09:05
FIRESIDE EXPERT KICK-OFF
Industry Trends: Innovations in Clinical Trial Design and Execution
Industry Trends: Innovations in Clinical Trial Design and Execution
• Innovations in Design (AI/ML, Knowledge Management)
• Innovations in Execution (DHTs, Decentralized Trials, and Site Experience)
Isabela Niculae, Head, Clinical Innovation and Digital Solutions, Global Clinical Operations, UCB
Joachim Lövin, DCT Specialist, Novo Nordisk
Additional Panelists TBA
09:30
CASE STUDY
Optimizing Drug Development with Actionable Data Insights:
Secondary Use of Data: Multimodal Data Assets
Optimizing Drug Development with Actionable Data Insights:
Secondary Use of Data: Multimodal Data Assets
• Roche's Approach and Leadership in Data Re-use - ROI and Responsibility to Patients
• Development of Datamarts to Generate Insights for Study and CDP Design
Marta Carrasco, Biomedical Data Insights Development Leader, Roche
09:50
CASE STUDY
Patient Recruitment Enabled through EHRs
Patient Recruitment Enabled through EHRs
Nadir Ammour, Global Lead, Clinical Innovation & External Partnerships, Sanofi
10:10
Transforming the Clinical Trial Industry with a Patient First Mindset
Alison Holland, Chief Customer Officer, Medable
10:30
Networking Break
CONTENT BLOCK 2
Accelerating Patient-Centric Trials
Accelerating Patient-Centric Trials
11:00
CASE STUDY
Navigating Operational Challenges of Multimodal DHT Trials
Navigating Operational Challenges of Multimodal DHT Trials
Speaker TBA
11:20
CASE STUDY
Scaling Clinical Innovation - The Novartis Operating Model for Sustainable Success
Scaling Clinical Innovation - The Novartis Operating Model for Sustainable Success
This session will explore how Novartis’s Clin Ops Innovation team is transforming clinical operations. Discover how their comprehensive operating model scales innovation through a structured framework, ensuring alignment with operational needs and challenges. Learn how they measure success with clear criteria, match specific innovations to operational requirements, and consistently assess the innovation landscape to identify new opportunities. This session will provide valuable insights into Novartis’s systematic approach to driving sustainable, value-driven innovation in clinical trials.
Scott Askin, Portfolio Innovation Director, Global Clinical Operations, Novartis
11:40
Bringing Clinical Trials Direct-to-Patient
Speaker TBA, Cambridge Cognition
12:00
PANEL
Identifying Innovations & Technologies Accelerating Patient-Centric Trials
Identifying Innovations & Technologies Accelerating Patient-Centric Trials
Lauren Sunshine, Director, Product Management, Digital Health, Bristol Myers Squibb
Bola Grace, Senior Director, Digital Health, Digital Biomarkers, GSK
Sam Hariry, Global Head, Clinical Innovation, Novartis Institutes for BioMedical Research (NIBR)
12:30
NETWORKING LUNCH
CONTENT BLOCK 3
Enhancing Diversity in Clinical Trials
Enhancing Diversity in Clinical Trials
13:30
PANEL
Patient Perspectives & Cultural Considerations in Clinical Trials
Patient Perspectives & Cultural Considerations in Clinical Trials
This panel will bring together a group of patients to explore how their perspectives on cultural considerations in clinical trials.
Moderated by: Steve Bourke, Founder, PersonalPulse
13:50
CASE STUDY
IHI READI
IHI READI
This session will explore the collaboration behind the IHI-funded project - IHI READI - aimed at fostering a more cohesive and integrated clinical studies ecosystem for underserved (US) and underrepresented (UR) communities.
Lea Proulx, Patient Voice Partner, Roche
14:10
CASE STUDY
End to End Inclusive Research
End to End Inclusive Research
What can early development bring to late stage development?
Thierry Lave, R&D Academy and Faculty Lead, Roche
14:30
FIRESIDE CHAT
Site Perspective on Diversity in Clinical Trials
Site Perspective on Diversity in Clinical Trials
• How are sites addressing recruitment diversity? How are patients actively participating in this discussion?
• How are people managing trust in the clinical trial system with the trust of digital health technologies?
Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare, NHS Trust
14:50
NETWORKING BREAK
CONTENT BLOCK 4
IDEAS INTO ACTION
IDEAS INTO ACTION
15:20
Driving AI Adoption within Clinical Operations
Speaker TBA
15:40
CASE STUDY
How MindMed is Deploying AI to do Analysis of Patient Interviews Around the Primary Endpoint of All Clinical Studies
How MindMed is Deploying AI to do Analysis of Patient Interviews Around the Primary Endpoint of All Clinical Studies
Dan Karlin, Chief Medical Officer, MindMed
16:00
Patient Perspective: First Hand Experience with DCTs
Patient Speaker TBA
16:25
CLOSING PANEL
Challenges of Implementation of DHTs
Challenges of Implementation of DHTs
Meri Kay Scott, Associate Vice President, Digital Health R&D, Eli Lilly & Company
Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare, NHS Trust
Matteo Lai, CEO, Empatica
16:55
Closing Reflection
Ernst Bos, Global Medical Director, Roche
Paul Cooper, Personalised Healthcare Strategy Leader, Roche
APÉRO & NETWORKING RECEPTION TO FOLLOW!
HOST SPONSOR
GOLD SPONSOR
GOLD SPONSOR
GOLD SPONSOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
SUPPORTING SPONSOR
Interested in Sponsorship or
Exhibition Opportunities?
Exhibition Opportunities?
Conference Venue
Roche Tower (Building 1)
The Clinical Trials Innovation Summit (26 June) and the Digital Biomarkers Summit (25 June) will both be held in the Auditorium of Building 1 on the Roche campus in Basel.
Address:
Roche Tower (Building 1)
Grenzacherstrasse 124
4070 Basel, Switzerland
About: The office high-rise, Building 1, is a key pillar of Roche's site development strategy. With its straightforward yet unmistakable design, it blends in perfectly with the Roche grounds and the Basel cityscape. With 41 floors and workspace for around 2,000 employees, the office high-rise also shows a clear commitment to the Basel site.
Address:
Roche Tower (Building 1)
Grenzacherstrasse 124
4070 Basel, Switzerland
About: The office high-rise, Building 1, is a key pillar of Roche's site development strategy. With its straightforward yet unmistakable design, it blends in perfectly with the Roche grounds and the Basel cityscape. With 41 floors and workspace for around 2,000 employees, the office high-rise also shows a clear commitment to the Basel site.
Hotel Room Block
Hyperion Hotel Basel
(4 Star Hotel) Hyperion Hotel Basel in Basel, Switzerland
Location: Messepl. 12, 4058 Basel, Switzerland
In Basel's tallest habitable building, the HYPERION Hotel Basel is next to the Basel Messe trade fair center and just a short walk from the Old Town. It offers a sauna and a fitness center. Each of the 224 non-smoking guest rooms offers panoramic views of the city, free WiFi, air conditioning, refreshing bath products, a safe, hair dryer, and flat-screen TV with Sky channels.
PanAgora Pharma has a conference room block at the Hyperion Hotel Basel - just 1km from Roche Building 1. To book your room at the preferred room block rate, please use this link: CTIS Room Block at Hyperion Hotel Basel
***The Room Block closes on 13 May 2025, so we encourage all attendees staying in Basel to please make your reservation before then.
